Business
Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure
New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical
About this update from Clover Health Investments, Corp.
[{"type":"text","content":"New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower) and readmissions (25% lower) in heart failure patients\nWILMINGTON, Del., May 01, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released research demonstrating how Counterpart Assistant (“CA”) use is associated with better management of congestive heart failure (“CHF”). The analysis, titled “Driving Clinical Excellence in Chronic Disease: Counterpart Assistant's Role in Heart Failure Care,” details the significant positive association among CHF patients between better clinical care and lower hospitalizations, and having a relationship with a PCP that uses Counterpart Assistant. Key highlights of the study include: A relationship with a CA provider was associated with better outcomes, including a lower average number of all-cause hospitalizations (18% lower) and 30-day readmissions (25% lower) for CHF patients enrolled in Clover Health’s Medicare Advantage (MA) plans.CA provides actionable insights at the point of care, which supports earlier detection of chronic disease, tracking of disease progression and severity, and guideline-based treatment.A relationship with a PCP who uses CA was associated with better clinical care for patients with CHF, including higher rates of outpatient cardiologist visits and in-home care management. \"At Counterpart Health, we are committed to developing technology solutions that truly augment the capabilities of our healthcare providers,\" stated Dr. David Tsay MD, PhD, Chief Medical Officer of Counterpart Health and co-author of the whitepaper. \"The results of this study on Counterpart Assistant and congestive heart failure demonstrate how providing clinicians with timely, data-driven insights can help lead to significant improvements in patient outcomes. This technology is designed to be a collaborative partner, empowering them to deliver even more effective and personalized care.\" CA has empowered providers in patient care by focusing on clinical excellence in chronic disease detection and mana...